Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon Guyatt

Showing results (21-30 of 743) with videos related to

Pageof 75
Sort By:
Journal of Clinical Epidemiology|July 14, 2020
Evidence-based medicine in times of crisisBenjamin Djulbegovic, Gordon Guyatt
Clinical Orthopaedics and Related Research|August 5, 2003
A guide to health measurementDianne Jackowski, Gordon Guyatt
Journal of Evidence-Based Medicine|February 26, 2011
Meta-analysis of randomized trials for health care interventions: one for all?Xin Sun, Gordon Guyatt
Circulation Journal : Official Journal of the Japanese Circulation Society|November 27, 2007
The risk factors for thromboembolism in nonvalvular atrial fibrillation and CHADS2 scoring in JapanMorio Aihara, Gordon Guyatt
Annals of Internal Medicine|January 4, 2021
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PADQiukui Hao, Gordon Guyatt
Polskie Archiwum Medycyny Wewnetrznej|December 2, 2016
Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman JaeschkeGordon Guyatt, Roman Jaeschke
Annals of Internal Medicine|January 24, 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shockBram Rochwerg, Gordon Guyatt
Journal of Clinical Epidemiology|June 30, 2025
Response to the letter 'Balancing methodological rigor and simplicity in ROBUST-RCT: is optional assessment of bias domains the ideal path forward'Ying Wang, Gordon Guyatt
Journal of Clinical Epidemiology|March 9, 2026
Misusing I<sup>2</sup> for Inconsistency, Overlooking OIS for Imprecision, and Ignoring the Continuum of Certainty Ratings: Common Pitfalls in GRADE AssessmentsPrashanti Eachempati, Gordon Guyatt
BMJ Evidence-Based Medicine|July 30, 2024
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemicArnav Agarwal, Gordon Guyatt
Pageof 75

Showing results (21-30 of 743) with videos related to

Sort By:
Pageof 75
Journal of Clinical Epidemiology|July 14, 2020
Evidence-based medicine in times of crisisBenjamin Djulbegovic, Gordon Guyatt
Clinical Orthopaedics and Related Research|August 5, 2003
A guide to health measurementDianne Jackowski, Gordon Guyatt
Journal of Evidence-Based Medicine|February 26, 2011
Meta-analysis of randomized trials for health care interventions: one for all?Xin Sun, Gordon Guyatt
Circulation Journal : Official Journal of the Japanese Circulation Society|November 27, 2007
The risk factors for thromboembolism in nonvalvular atrial fibrillation and CHADS2 scoring in JapanMorio Aihara, Gordon Guyatt
Annals of Internal Medicine|January 4, 2021
Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PADQiukui Hao, Gordon Guyatt
Polskie Archiwum Medycyny Wewnetrznej|December 2, 2016
Aspirin in prevention of cardiovascular events. Dr. Gordon Guyatt in an interview with Dr. Roman JaeschkeGordon Guyatt, Roman Jaeschke
Annals of Internal Medicine|January 24, 2017
In patients with severe sepsis, hydrocortisone did not prevent progression to septic shockBram Rochwerg, Gordon Guyatt
Journal of Clinical Epidemiology|June 30, 2025
Response to the letter 'Balancing methodological rigor and simplicity in ROBUST-RCT: is optional assessment of bias domains the ideal path forward'Ying Wang, Gordon Guyatt
Journal of Clinical Epidemiology|March 9, 2026
Misusing I<sup>2</sup> for Inconsistency, Overlooking OIS for Imprecision, and Ignoring the Continuum of Certainty Ratings: Common Pitfalls in GRADE AssessmentsPrashanti Eachempati, Gordon Guyatt
BMJ Evidence-Based Medicine|July 30, 2024
Successes, shortcomings and learning opportunities for evidence-based medicine from the COVID-19 pandemicArnav Agarwal, Gordon Guyatt
Pageof 75